Canada markets closed

Vaxart, Inc. (VXRT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.3000+0.0100 (+0.78%)
At close: 04:00PM EDT
1.2800 -0.02 (-1.54%)
After hours: 06:14PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close1.2900
Open1.3300
Bid1.2700 x 700
Ask1.3200 x 300
Day's Range1.2800 - 1.4100
52 Week Range0.5300 - 1.5900
Volume2,778,684
Avg. Volume2,033,181
Market Cap226.021M
Beta (5Y Monthly)0.44
PE Ratio (TTM)N/A
EPS (TTM)-0.5700
Earnings DateMay 02, 2024 - May 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateNov 09, 2012
1y Target Est5.00
  • GlobeNewswire

    Vaxart to Present at World Vaccine Congress Washington 2024 on April 3

    SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, will present at the World Vaccine Congress Washington 2024 in Washington, D.C. on Wednesday, April 3, 2024. The Company has appeared repeatedly at the annual event in Washington, D.C. Presentation Information: Title: Moving the needle: Blocking transmission and boosting existing vaccines by oral tablet vaccinationSpeaker: Dr. Sean

  • GlobeNewswire

    Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    SOUTH SAN FRANCISCO, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” or “Vaxart”) today announced that the Compensation Committee of the Board of Directors approved certain equity awards to the Company’s new President and Chief Executive Officer, Steven Lo, effective March 18, 2024. The awards were made pursuant to the Company’s previously disclosed offer letter with Mr. Lo, and as a material inducement to his joining the Company as President and Chief Execu

  • Simply Wall St.

    Estimating The Intrinsic Value Of Vaxart, Inc. (NASDAQ:VXRT)

    Key Insights Using the 2 Stage Free Cash Flow to Equity, Vaxart fair value estimate is US$0.90 With US$1.08 share...